There is a critical need to review current treatment strategies for the increasingly common problem of medication overuse headaches (MOH).
“MOH is associated with severe disability, unmet treatment need and little clinical data to support current management strategies” says neurology expert Professor David W Dodick from the Mayo Clinic…
MOH, previously known as rebound headache, drug-induced headache or drug-misuse headache, is a headache that occurs at least 15 days a month when patients overuse medication.
“Tolerance to the analgesic effect of the acute medication develops over time, consumption may increase and patients may show withdrawal symptoms when they stop the overused mediation” explains Professor Dodick. “We estimate that the condition affects one in every 100 adults and one in every 200 adolescents worldwide, which is a considerable number.
“For example, in the USA 60 per cent of people with chronic daily headaches attending headache clinics have MOH. Data from a physician study suggests that it may be the third most frequent type of headache after migraines and tension-type headaches.
The international papers that accompany Dr Dodick’s overview show that MOH is a common problem, but the incidence, causes and treatment vary from country to country.
Yet another interesting piece of research on an illness that may seem obscure to some – if you ain’t suffering or dedicated to the prevention and cure of the ailment.
Good luck to Dr. Dodick and his new task as an editor.